# PanOptica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/panoptica

- Industry: Pharmaceuticals
- Headquarters: Bernardsville, US
- Website: www.panopticapharma.com
- Total disclosed funding: $71M
- Latest round: Series B (Apr 9, 2019)
- Investors on record: 3

## About

PanOptica Inc. specializes in developing innovative digital solutions that enhance online presence and streamline content management for a diverse clientele, including bloggers and enterprises.Founded in 2009 in Bernardsville, US, PanOptica Inc. focuses on providing digital solutions. The company has completed a total of 6 deals, with its most recent funding round being a Series B, which raised USD 10.47 mn in April 2019 from SV Health Investors and Third Rock Ventures, bringing the total amount raised to USD 10.47 mn and a current company valuation of USD 70.28 mn. The CEO is David Bingaman, and the founder is Paul Chaney.PanOptica Inc. offers a comprehensive suite of digital solutions focused on enhancing online presence and content management. Their flagship product is a robust content management system that allows users to create, manage, and optimize websites efficiently. The platform caters to a wide range of clients, providing customization tools, theme selections, and plugin integrations. Additionally, premium hosting services, security plugins, and support resources are available to ensure optimal website functionality, primarily targeting markets in North America, Europe, and parts of Asia.The company generates revenue through subscription-based models and one-time purchases of premium services. Customers can choose from various pricing plans that cater to different needs, from basic plans for bloggers to advanced packages for businesses that include additional storage and security features. Furthermore, PanOptica Inc. collaborates with web developers and agencies, enabling them to resell its services, thereby extending its market reach through B2B transactions.Looking ahead, PanOptica Inc. is strategizing to enhance its product offerings with new solutions aimed at improving user experience. The company plans to expand into additional markets across Europe and Asia by the end of 2022. The recent Series B funding of USD 10.47 mn will be utilized to support these initiatives, including the development of new products and the expansion into targeted geographic regions.

## Funding rounds

- Series B, Apr 9, 2019, $10M — SV Health Investors, Third Rock Ventures
- Series B, Oct 12, 2017, $6.3M — SV Health Investors, Third Rock Ventures
- Series B, May 24, 2016, $11M — SV Health Investors, Third Rock Ventures
- Series B, Apr 10, 2014, $13M — SV Health Investors, Novo Holdings, Third Rock Ventures
- Series A, Jan 4, 2011, $30M — SV Health Investors, Third Rock Ventures
- Seed, Jun 1, 2009 — SV Health Investors

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed, Series A, Series B
- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A, Series B
- Novo Holdings — Series B